サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684489

アイヘルス製品の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）

Eye Health Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アイヘルス製品の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年03月20日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

重要考察

  • アイヘルス製品の市場規模：30億1,940万米ドル（2025年）
  • 予測される市場金額：50億930万米ドル（2032年）
  • 世界市場の成長率：7.50%（2025年～2032年のCAGR）

アイヘルス製品市場 - レポート範囲

アイヘルス製品市場には、視力改善や眼科関連疾患の予防を目的とした栄養補助食品や特殊製剤が含まれます。これらの製品には、ルテイン、ゼアキサンチン、オメガ3脂肪酸、抗酸化物質、フラボノイドなどの必須栄養素が含まれており、目の機能と全体的な健康を支援します。視力ケアに対する意識の高まり、眼疾患の有病率の上昇、予防医療ソリューションに対する消費者の需要の高まりにより、市場は拡大しています。

市場成長の促進要因

加齢黄斑変性（AMD）、白内障、ドライアイ症候群の罹患率の上昇など、複数の要因が世界のアイヘルス製品市場の成長を促進しています。デジタル機器の使用によるスクリーンタイムの増加は、視力に関連する問題の増加につながっており、アイヘルスサプリメントの需要を促進しています。さらに、栄養の研究の進行と老年人口の増加が、市場成長をさらに促進しています。アイヘルス向けのマルチビタミンブレンドのような革新的な製剤の利用可能性も、製品の採用を促進しています。

市場抑制要因

大きな成長可能性があるにもかかわらず、アイヘルス製品市場は、高い製品コストや発展途上国市場における低い認知度といった課題に直面しています。また、サプリメントの製法が標準化されていないことや、健康効果の表示に関連する規制上の課題も、市場拡大の妨げになる可能性があります。さらに、処方薬や外科的介入などの代替治療法のプレゼンスは、アイヘルスサプリメントにとっての競合上の課題となる可能性があります。

市場機会

アイヘルス製品市場は、天然材料や植物由来のサプリメントに対する需要の高まりにより、大きな成長機会をもたらしています。個別化栄養とデジタルヘルスソリューションの統合により、製品の有効性と消費者のエンゲージメントが高まると予測されます。さらに、医療従事者、眼科医、eコマースプラットフォームとの戦略的パートナーシップは、市場浸透を促進する可能性があります。特に新興経済圏における流通網の拡大は、市場成長にさらに寄与するとみられます。

当レポートでは、世界のアイヘルス製品市場について調査し、成長促進要因、動向、機会、課題などの市場力学の詳細な分析を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲/分類
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主な市場動向

  • 市場に影響を与える主要動向
  • 製品のイノベーション/開発の動向

第4章 重要な成功要因

  • 製品採用率 - 主な統計
  • 規制シナリオ
  • 疾病の疫学
  • 製品のUSPの分析
  • PESTEL分析
  • ポーターの分析

第5章 市場の背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機の分析

  • COVID-19と影響の分析
    • 成分別
    • 適応症別
    • 形状別
    • 地域別
  • 市場シナリオ（2021年）

第7章 世界のアイヘルス製品市場の需要見通し（2019年～2032年）

  • 市場金額の実績の分析（2019年～2024年）
  • 現在と将来の市場金額の分析と予測（2025年～2032年）
    • 前年比成長動向の分析
    • 絶対的収益機会の分析

第8章 世界のアイヘルス製品市場の見通し（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：成分別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：成分別（2025年～2032年）
    • ルテイン、ゼアキサンチン
    • 抗酸化物質
    • オメガ3脂肪酸
    • コエンザイムQ10
    • フラボノイド
    • アスタキサンチン
    • アルファリポ酸
    • その他の成分
  • 市場の魅力分析：原料別

第9章 世界のアイヘルス製品市場の見通し（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：適応症別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：適応症別（2025年～2032年）
    • 加齢黄斑変性（AMD）
    • 白内障
    • ドライアイ症候群
    • その他の適応症
  • 市場の魅力分析：適応症別

第10章 世界のアイヘルス製品市場の見通し（2019年～2032年）

  • イントロダクション/主な調査結果
  • 市場規模の実績の分析：形状別（2019年～2024年）
  • 現在と将来の市場規模の分析と予測：形状別（2025年～2032年）
    • 錠剤
    • カプセル
    • その他
  • 市場の魅力分析：形状別

第11章 世界のアイヘルス製品市場の見通し（2019年～2032年）

  • イントロダクション
  • 市場規模の実績の分析：地域別（2019年～2024年）
  • 現在と将来の市場金額の分析と予測（2025年～2032年）
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第12章 北米のアイヘルス製品市場の見通し（2019年～2032年）

第13章 ラテンアメリカのアイヘルス製品市場の見通し（2019年～2032年）

第14章 欧州のアイヘルス製品市場の見通し（2019年～2032年）

第15章 東アジアのアイヘルス製品市場の見通し（2019年～2032年）

第16章 南アジアのアイヘルス製品市場の見通し（2019年～2032年）

第17章 オセアニアのアイヘルス製品市場の見通し（2019年～2032年）

第18章 中東・アフリカのアイヘルス製品市場の見通し（2019年～2032年）

第19章 市場構造分析

  • 市場の分析：企業のTier別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Pfizer Inc.
    • The Nature's Bounty Co.
    • Amway International
    • Bausch+Lomb
    • Nutrivein
    • ZeaVision LLC
    • Kemin Industries, Inc.
    • EyeScience
    • Nutrachamps
    • Bausch Health Companies Inc.
    • Vitabiotics Ltd.

第21章 使用される前提条件と頭字語

第22章 調査手法

目次
Product Code: PMRREP5465

Persistence Market Research has recently released a comprehensive report on the global Eye Health Products Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers valuable insights into the market structure, equipping stakeholders with the knowledge needed to make strategic decisions.

Key Insights:

  • Eye Health Products Market Size (2025E): USD 3,019.40 Mn
  • Projected Market Value (2032F): USD 5,009.30 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 7.50%

Eye Health Products Market - Report Scope:

The Eye Health Products Market includes dietary supplements and specialized formulations aimed at improving vision and preventing eye-related disorders. These products contain essential nutrients such as lutein, zeaxanthin, omega-3 fatty acids, antioxidants, and flavonoids, which support eye function and overall ocular health. The market is expanding due to increasing awareness about vision care, the rising prevalence of eye disorders, and growing consumer demand for preventive healthcare solutions.

Market Growth Drivers:

Several factors are fueling the growth of the global Eye Health Products Market, including the rising incidence of age-related macular degeneration (AMD), cataracts, and dry eye syndrome. Growing screen time due to digital device usage has led to an increase in vision-related issues, driving demand for eye health supplements. Additionally, advancements in nutritional research, coupled with the expanding geriatric population, are further propelling market growth. The availability of innovative formulations, such as multivitamin blends for eye health, is also enhancing product adoption.

Market Restraints:

Despite strong growth potential, the Eye Health Products Market faces challenges such as high product costs and limited awareness in developing regions. The lack of standardization in supplement formulations and regulatory challenges related to claims of health benefits may also hinder market expansion. Additionally, the presence of alternative treatment methods, such as prescription medications and surgical interventions, could pose a competitive challenge to eye health supplements.

Market Opportunities:

The Eye Health Products Market presents significant opportunities for growth due to increasing demand for natural and plant-based supplements. The integration of personalized nutrition and digital health solutions is expected to enhance product effectiveness and consumer engagement. Additionally, strategic partnerships with healthcare professionals, ophthalmologists, and e-commerce platforms can drive market penetration. Expanding distribution networks, particularly in emerging economies, will further contribute to market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the Eye Health Products Market?
  • Which ingredients and formulations are gaining the most traction in the eye health industry?
  • How is digitalization and increased screen exposure impacting market trends?
  • Who are the major players in the Eye Health Products Market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future outlooks for the global Eye Health Products Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Eye Health Products Market, including The Nature's Bounty Co., Pfizer Inc., Amway International, and Bausch + Lomb, are focusing on product innovation, clinical research, and strategic collaborations to strengthen their market position. Companies are investing in scientific advancements to develop high-potency supplements with enhanced bioavailability. E-commerce expansion, digital marketing strategies, and retail partnerships are also being leveraged to improve consumer outreach. The focus on sustainability and clean-label products is becoming a key differentiator in the competitive landscape.

Key Companies Profiled:

  • The Nature's Bounty Co.
  • Pfizer Inc.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

Eye Health Products Industry Research by Category:

By Ingredient:

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic Acid
  • Other Ingredients

By Indication:

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Other Indications

By Form:

  • Tablet
  • Capsule
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmaps
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Rate - Key Statistics
  • 4.2. Regulatory Scenario
  • 4.3. Disease Epidemiology
  • 4.4. Product USP Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Eye Care Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Eye Disorders
    • 5.2.2. Growing Awareness of Eye Diseases
    • 5.2.3. Rising Demand of Eye Health Products Amongst Millennials
    • 5.2.4. Advertisement from Manufacturers
    • 5.2.5. Mergers and Acquisitions
    • 5.2.6. Prevalence of AMD in Elderly Population
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Ingredient
    • 6.1.2. By Indication
    • 6.1.3. By Form
    • 6.1.4. By Region
  • 6.2. 2021 Market Scenario

7. Global Eye Health Products Market Demand Outlook, 2019 - 2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
  • 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Eye Health Products Market Outlook, 2019 - 2032

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis, by Ingredient, 2019-2024
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Ingredient, 2025-2032
    • 8.3.1. Lutein and Zeaxanthin
    • 8.3.2. Antioxidants
    • 8.3.3. Omega-3 Fatty Acids
    • 8.3.4. Coenzyme Q10
    • 8.3.5. Flavonoids
    • 8.3.6. Astaxanthin
    • 8.3.7. Alpha-Lipoic Acid
    • 8.3.8. Other Ingredients
  • 8.4. Market Attractiveness Analysis, by Ingredient

9. Global Eye Health Products Market Outlook, 2019 - 2032

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2025-2032
    • 9.3.1. Age-related Macular Degeneration (AMD)
    • 9.3.2. Cataract
    • 9.3.3. Dry Eye Syndrome
    • 9.3.4. Other Indications
  • 9.4. Market Attractiveness Analysis, by Indication

10. Global Eye Health Products Market Outlook, 2019 - 2032

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Form, 2019-2024
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Form, 2025-2032
    • 10.3.1. Tablet
    • 10.3.2. Capsule
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Form

11. Global Eye Health Products Market Outlook, 2019 - 2032

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2024
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Eye Health Products Market Outlook, 2019 - 2032

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Ingredient
    • 12.3.3. By Indication
    • 12.3.4. By Form
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Ingredient
    • 12.4.3. By Indication
    • 12.4.4. By Form
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Eye Health Products Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Ingredient
        • 12.7.1.2.2. By Indication
        • 12.7.1.2.3. By Form
    • 12.7.2. Canada Eye Health Products Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Ingredient
        • 12.7.2.2.2. By Indication
        • 12.7.2.2.3. By Form

13. Latin America Eye Health Products Market Outlook, 2019 - 2032

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Ingredient
    • 13.3.3. By Indication
    • 13.3.4. By Form
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Ingredient
    • 13.4.3. By Indication
    • 13.4.4. By Form
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Eye Health Products Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Ingredient
        • 13.7.1.2.2. By Indication
        • 13.7.1.2.3. By Form
    • 13.7.2. Brazil Eye Health Products Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Ingredient
        • 13.7.2.2.2. By Indication
        • 13.7.2.2.3. By Form
    • 13.7.3. Argentina Eye Health Products Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Ingredient
        • 13.7.3.2.2. By Indication
        • 13.7.3.2.3. By Form

14. Europe Eye Health Products Market Outlook, 2019-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Ingredient
    • 14.3.3. By Indication
    • 14.3.4. By Form
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Ingredient
    • 14.4.3. By Indication
    • 14.4.4. By Form
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Eye Health Products Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Ingredient
        • 14.7.1.2.2. By Indication
        • 14.7.1.2.3. By Form
    • 14.7.2. Italy Eye Health Products Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Ingredient
        • 14.7.2.2.2. By Indication
        • 14.7.2.2.3. By Form
    • 14.7.3. France Eye Health Products Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Ingredient
        • 14.7.3.2.2. By Indication
        • 14.7.3.2.3. By Form
    • 14.7.4. U.K. Eye Health Products Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Ingredient
        • 14.7.4.2.2. By Indication
        • 14.7.4.2.3. By Form
    • 14.7.5. Spain Eye Health Products Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Ingredient
        • 14.7.5.2.2. By Indication
        • 14.7.5.2.3. By Form
    • 14.7.6. BENELUX Eye Health Products Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Ingredient
        • 14.7.6.2.2. By Indication
        • 14.7.6.2.3. By Form
    • 14.7.7. Russia Eye Health Products Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Ingredient
        • 14.7.7.2.2. By Indication
        • 14.7.7.2.3. By Form

15. East Asia Eye Health Products Market Outlook, 2019 - 2032

  • 15.1. Introduction
  • 15.2. Historical Market Form (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Ingredient
    • 15.3.3. By Indication
    • 15.3.4. By Form
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Ingredient
    • 15.4.2. By Indication
    • 15.4.3. By Form
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Eye Health Products Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Ingredient
        • 15.7.1.2.2. By Indication
        • 15.7.1.2.3. By Form
    • 15.7.2. Japan Eye Health Products Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Ingredient
        • 15.7.2.2.2. By Indication
        • 15.7.2.2.3. By Form
    • 15.7.3. South Korea Eye Health Products Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Ingredient
        • 15.7.3.2.2. By Indication
        • 15.7.3.2.3. By Form

16. South Asia Eye Health Products Market Outlook, 2019-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Ingredient
    • 16.3.3. By Indication
    • 16.3.4. By Form
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Ingredient
    • 16.4.3. By Indication
    • 16.4.4. By Form
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Eye Health Products Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Ingredient
        • 16.7.1.2.2. By Indication
        • 16.7.1.2.3. By Form
    • 16.7.2. Indonesia Eye Health Products Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Ingredient
        • 16.7.2.2.2. By Indication
        • 16.7.2.2.3. By Form
    • 16.7.3. Malaysia Eye Health Products Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Ingredient
        • 16.7.3.2.2. By Indication
        • 16.7.3.2.3. By Form
    • 16.7.4. Thailand Eye Health Products Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Ingredient
        • 16.7.4.2.2. By Indication
        • 16.7.4.2.3. By Form

17. Oceania Eye Health Products Market Outlook, 2019 - 2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Ingredient
    • 17.3.3. By Indication
    • 17.3.4. By Form
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Ingredient
    • 17.4.3. By Indication
    • 17.4.4. By Form
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Eye Health Products Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Ingredient
        • 17.7.1.2.2. By Indication
        • 17.7.1.2.3. By Form
    • 17.7.2. New Zealand Eye Health Products Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Ingredient
        • 17.7.2.2.2. By Indication
        • 17.7.2.2.3. By Form

18. Middle East and Africa (MEA) Eye Health Products Market Outlook, 2019 - 2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
  • 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Ingredient
    • 18.3.3. By Indication
    • 18.3.4. By Form
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Ingredient
    • 18.4.2. By Indication
    • 18.4.3. By Form
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Eye Health Products Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Ingredient
        • 18.7.1.2.2. By Indication
        • 18.7.1.2.3. By Form
    • 18.7.2. Turkey Eye Health Products Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Ingredient
        • 18.7.2.2.2. By Indication
        • 18.7.2.2.3. By Form
    • 18.7.3. South Africa Eye Health Products Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Ingredient
        • 18.7.3.2.2. By Indication
        • 18.7.3.2.3. By Form
    • 18.7.4. North Africa Eye Health Products Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Ingredient
        • 18.7.4.2.2. By Indication
        • 18.7.4.2.3. By Form

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Pfizer Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Ingredient Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Ingredient Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. The Nature's Bounty Co.
      • 20.3.2.1. Overview
      • 20.3.2.2. Ingredient Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Ingredient Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Amway International
      • 20.3.3.1. Overview
      • 20.3.3.2. Ingredient Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Ingredient Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Bausch + Lomb
      • 20.3.4.1. Overview
      • 20.3.4.2. Ingredient Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Ingredient Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Nutrivein
      • 20.3.5.1. Overview
      • 20.3.5.2. Ingredient Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Ingredient Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. ZeaVision LLC
      • 20.3.6.1. Overview
      • 20.3.6.2. Ingredient Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Ingredient Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Kemin Industries, Inc.
      • 20.3.7.1. Overview
      • 20.3.7.2. Ingredient Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Ingredient Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. EyeScience
      • 20.3.8.1. Overview
      • 20.3.8.2. Ingredient Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Ingredient Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Nutrachamps
      • 20.3.9.1. Overview
      • 20.3.9.2. Ingredient Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Ingredient Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Bausch Health Companies Inc.
      • 20.3.10.1. Overview
      • 20.3.10.2. Ingredient Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Ingredient Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Vitabiotics Ltd.
      • 20.3.11.1. Overview
      • 20.3.11.2. Ingredient Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Ingredient Strategy
        • 20.3.11.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology